Ipsen publishes positive phase IV data in stress ulcer

French pharmaceutical group Ipsen announces positive data from a phase IV clinical trial in stress ulcer.

Published 8sem1 source

≈ 18sSpeed

The fact

These positive results validate treatment efficacy in an important therapeutic indication.

The publication strengthens Ipsen's product portfolio and clinical credibility.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on May 20, 2026